These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34632641)

  • 1. Sequential genetic testing of living-related donors for inherited renal disease to promote informed choice and enhance safety of living donation.
    Thomas CP; Gupta S; Freese ME; Chouhan KK; Dantuma MI; Holanda DG; Katz DA; Darbro BW; Mansilla MA; Smith RJ
    Transpl Int; 2021 Dec; 34(12):2696-2705. PubMed ID: 34632641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening of Living Kidney Donors for Genetic Diseases Using a Comprehensive Genetic Testing Strategy.
    Thomas CP; Mansilla MA; Sompallae R; Mason SO; Nishimura CJ; Kimble MJ; Campbell CA; Kwitek AE; Darbro BW; Stewart ZA; Smith RJ
    Am J Transplant; 2017 Feb; 17(2):401-410. PubMed ID: 27434427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Initial experience from a renal genetics clinic demonstrates a distinct role in patient management.
    Thomas CP; Freese ME; Ounda A; Jetton JG; Holida M; Noureddine L; Smith RJ
    Genet Med; 2020 Jun; 22(6):1025-1035. PubMed ID: 32203225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic testing in the assessment of living related kidney donors at risk of autosomal dominant polycystic kidney disease.
    Simms RJ; Travis DL; Durkie M; Wilson G; Dalton A; Ong AC
    Transplantation; 2015 May; 99(5):1023-9. PubMed ID: 25340609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and Nonpatients.
    Harris DD; Fleishman A; Pavlakis M; Pollak MR; Baliga PK; Rohan V; Kayler LK; Rodrigue JR
    J Surg Res; 2022 Sep; 277():116-124. PubMed ID: 35489216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective genetic analysis illustrates the spectrum of autosomal Alport syndrome in a case of living-related donor kidney transplantation.
    Petzold F; Bachmann A; Bergmann C; Helmchen U; Halbritter J
    BMC Nephrol; 2019 Sep; 20(1):340. PubMed ID: 31477057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why Potential Living Kidney Donors Do Not Proceed for Donation: A Single-Center Experience.
    AlBugami MM; AlOtaibe FE; Boqari D; AlAbadi AM; Hamawi K; Bel'eed-Akkari K
    Transplant Proc; 2019 Mar; 51(2):504-508. PubMed ID: 30879577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Living donor kidney transplantation in patients with hereditary nephropathies.
    Niaudet P
    Nat Rev Nephrol; 2010 Dec; 6(12):736-43. PubMed ID: 20877305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA testing for live kidney donors at risk for autosomal dominant polycystic kidney disease.
    Huang E; Samaniego-Picota M; McCune T; Melancon JK; Montgomery RA; Ugarte R; Kraus E; Womer K; Rabb H; Watnick T
    Transplantation; 2009 Jan; 87(1):133-7. PubMed ID: 19136903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and long term mineral metabolism adaptation in living kidney donors: a prospective study.
    Ponte B; Trombetti A; Hadaya K; Ernandez T; Fumeaux D; Iselin C; Martin PY; de Seigneux S
    Bone; 2014 May; 62():36-42. PubMed ID: 24495507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Why Living Kidney Donor Candidates Are Turned Down? A Single-Center Cohort Study.
    Altheaby A; Almukhlifi A; Aldoukhi A; Alfaleh A; Aboalsamah G; Alshareef A; Alruwaymi M; Bin Saad K; Arabi Z
    Cureus; 2020 Aug; 12(8):e9877. PubMed ID: 32963917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kidney function, albuminuria and cardiovascular risk factors in post-operative living kidney donors: a single-center, cross-sectional study.
    Yazawa M; Kido R; Shibagaki Y; Yasuda T; Nakazawa R; Sasaki H; Sato Y; Chikaraishi T; Kimura K
    Clin Exp Nephrol; 2011 Aug; 15(4):514-21. PubMed ID: 21499989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presymptomatic testing for adult onset polycystic kidney disease in at-risk kidney transplant donors.
    Hannig VL; Hopkins JR; Johnson HK; Phillips JA; Reeders ST
    Am J Med Genet; 1991 Sep; 40(4):425-8. PubMed ID: 1746605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes-free survival among living kidney donors and non-donors with obesity: A longitudinal cohort study.
    Killian AC; Reed RD; McLeod MC; MacLennan PA; Kumar V; Pittman SE; Maynor AG; Stanford LA; Baker GA; Schinstock CA; Silkensen JR; Roll GR; Segev DL; Orandi BJ; Lewis CE; Locke JE
    PLoS One; 2022; 17(11):e0276882. PubMed ID: 36399462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical genetic diagnostics in Danish autosomal dominant polycystic kidney disease patients reveal possible founder variants.
    Nielsen ML; Lildballe DL; Rasmussen M; Bojesen A; Birn H; Sunde L
    Eur J Med Genet; 2021 Apr; 64(4):104183. PubMed ID: 33639313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Living-Donor Kidney Transplantation: Reducing Financial Barriers to Live Kidney Donation--Recommendations from a Consensus Conference.
    Tushla L; Rudow DL; Milton J; Rodrigue JR; Schold JD; Hays R;
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1696-702. PubMed ID: 26002904
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mosaicism in autosomal dominant polycystic kidney disease revealed by genetic testing to enable living related renal transplantation.
    Connor A; Lunt PW; Dolling C; Patel Y; Meredith AL; Gardner A; Hamilton NK; Dudley CR
    Am J Transplant; 2008 Jan; 8(1):232-7. PubMed ID: 17973957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why Do Not All Living Kidney Donor Candidates Are Accepted for Donation? A Pediatric Center Experience.
    Navarro-González A; Arreola-Gutiérrez M; Barrera-De León JC; Calderón-Alvarado AB; Becerra-Moscoso MR
    Transplant Proc; 2023; 55(6):1469-1472. PubMed ID: 36948962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis and screening of autosomal dominant polycystic kidney disease.
    Pei Y; Watnick T
    Adv Chronic Kidney Dis; 2010 Mar; 17(2):140-52. PubMed ID: 20219617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Approach to genetic testing to optimize the safety of living donor transplantation in Alport syndrome spectrum.
    Caliskan Y; Lentine KL
    Pediatr Nephrol; 2022 Sep; 37(9):1981-1994. PubMed ID: 35088158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.